雜志介紹

Clinical And Experimental Pharmacology And Physiology雜志介紹

《Clinical And Experimental Pharmacology And Physiology》是一本以English為主的未開放獲取國際優秀期刊，中文名稱臨床和實驗藥理學和生理學，本刊主要出版、報道醫學-PHARMACOLOGY & PHARMACY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為2.4，最新CiteScore 指數為6.2。

本刊近期中國學者發表的論文主要有：

• Fibroblast growth factor 10 ameliorates renal ischaemia-reperfusion injury by attenuating mitochondrial damage

  Author: Yu, Lixia; Yi, Xiaojiao; Yu, Cailong; Wang, Fugen; Tan, Xiaohua

• A gain of function ryanodine receptor 2 mutation (R1760W-RyR2) in catecholaminergic polymorphic ventricular tachycardia

  Author: Li, Siyuan; Lv, Tingting; Yang, Jing; Li, Kun; Yang, Ying; Zhang, Ping

• Molecular insight of p53/Sp1/MUC5AC axis in the tumorigenesis and progression of lung adenocarcinoma

  Author: Zhang, Jing; He, Wenjuan; Hu, Xiangying; Fang, Xia; Wang, Guosheng; Tang, Rongjuan; Zhang, Ping; Li, Qiang

• SIRT1 targeted by miR-211-5p regulated proliferation and apoptosis of Dex-treated growth plate chondrocytes via mediating SOX2

  Author: Cheng, Deliang; Zhang, Lijun; Liang, Xiaoju

英文介紹

Clinical And Experimental Pharmacology And Physiology雜志英文介紹

Clinical and Experimental Pharmacology and Physiology is an international journal founded in 1974 by Mike Rand, Austin Doyle, John Coghlan and Paul Korner. Our focus is new frontiers in physiology and pharmacology, emphasizing the translation of basic research to clinical practice. We publish original articles, invited reviews and our exciting, cutting-edge Frontiers-in-Research series’.